Literature DB >> 16699814

Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

Jana Trebatická1, Sona Kopasová, Zuzana Hradecná, Kamil Cinovský, Igor Skodácek, Ján Suba, Jana Muchová, Ingrid Zitnanová, Iweta Waczulíková, Peter Rohdewald, Zdenka Duracková.   

Abstract

Attention Deficit/Hyperactivity Disorder (ADHD) is the most common psychiatric disorder in children. Pycnogenol, an extract from the bark of the French maritime pine, consisting of phenolic acids, catechin, taxifolin and procyanidins, has shown improvement of ADHD in case reports and in an open study. Aim of the present study was to evaluate the effect of Pycnogenol on ADHD symptoms. Sixty-one children were supplemented with 1 mg/kg/day Pycnogenol or placebo over a period of 4 weeks in a randomised, placebo-controlled, doubleblind study. Patients were examined at start of trial, 1 month after treatment and 1 month after end of treatment period by standard questionnaires: CAP (Child Attention Problems) teacher rating scale, Conner's Teacher Rating Scale (CTRS), the Conner's Parent Rating Scale (CPRS) and a modified Wechsler Intelligence Scale for children. Results show that 1-month Pycnogenol administration caused a significant reduction of hyperactivity, improves attention and visual-motoric coordination and concentration of children with ADHD. In the placebo group no positive effects were found. One month after termination of Pycnogenol administration a relapse of symptoms was noted. Our results point to an option to use Pycnogenol as a natural supplement to relieve ADHD symptoms of children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699814     DOI: 10.1007/s00787-006-0538-3

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  14 in total

1.  Pycnogenol for ADHD?

Authors:  S W Heimann
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-04       Impact factor: 8.829

Review 2.  NO at work.

Authors:  H H Schmidt; U Walter
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

Review 3.  Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol.

Authors:  L Packer; G Rimbach; F Virgili
Journal:  Free Radic Biol Med       Date:  1999-09       Impact factor: 7.376

Review 4.  Attention-deficit/hyperactivity disorder: a selective overview.

Authors:  Joseph Biederman
Journal:  Biol Psychiatry       Date:  2004-12-18       Impact factor: 13.382

Review 5.  Co-existing disorders in ADHD -- implications for diagnosis and intervention.

Authors:  Christopher Gillberg; I Carina Gillberg; Peder Rasmussen; Björn Kadesjö; Henrik Söderström; Mania Råstam; Mato Johnson; Aribert Rothenberger; Lena Niklasson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

6.  The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

7.  An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  S Tenenbaum; J C Paull; E P Sparrow; D K Dodd; L Green
Journal:  J Atten Disord       Date:  2002-09       Impact factor: 3.256

8.  Endothelium-dependent vascular effects of Pycnogenol.

Authors:  D F Fitzpatrick; B Bing; P Rohdewald
Journal:  J Cardiovasc Pharmacol       Date:  1998-10       Impact factor: 3.105

9.  Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain.

Authors:  K Yamada; Y Noda; S Nakayama; Y Komori; H Sugihara; T Hasegawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 10.  Cognitive enhancement. New strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems.

Authors:  D K Ingram; A Shimada; E L Spangler; H Ikari; J Hengemihle; H Kuo; N Greig
Journal:  Ann N Y Acad Sci       Date:  1996-06-15       Impact factor: 5.691

View more
  15 in total

Review 1.  Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners.

Authors:  Elizabeth A Hurt; L Eugene Arnold; Nicholas Lofthouse
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 2.  Nutritional supplements for the treatment of ADHD.

Authors:  Michael H Bloch; Jilian Mulqueen
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2014-08-12

3.  Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract.

Authors:  S Iravani; B Zolfaghari
Journal:  Res Pharm Sci       Date:  2011-01

Review 4.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 5.  Markers of Oxidative Stress and Neuroprogression in Depression Disorder.

Authors:  Magdaléna Vaváková; Zdeňka Ďuračková; Jana Trebatická
Journal:  Oxid Med Cell Longev       Date:  2015-05-20       Impact factor: 6.543

Review 6.  Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.

Authors:  James Ahn; Hyung Seok Ahn; Jae Hoon Cheong; Ike Dela Peña
Journal:  Neural Plast       Date:  2016-02-04       Impact factor: 3.599

7.  (-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats.

Authors:  M Kluknavsky; P Balis; A Puzserova; J Radosinska; A Berenyiova; M Drobna; S Lukac; J Muchova; I Bernatova
Journal:  Oxid Med Cell Longev       Date:  2016-11-03       Impact factor: 6.543

8.  Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial.

Authors:  Annelies A J Verlaet; Berten Ceulemans; Helene Verhelst; Dirk Van West; Tess De Bruyne; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Trials       Date:  2017-03-28       Impact factor: 2.279

9.  Complementary and alternative therapies for pediatric attention deficit hyperactivity disorder: a descriptive review.

Authors:  H Russell Searight; Kayla Robertson; Todd Smith; Scott Perkins; Barbara K Searight
Journal:  ISRN Psychiatry       Date:  2012-12-26

10.  Pine bark (Pinus spp.) extract for treating chronic disorders.

Authors:  Nina U Robertson; Anel Schoonees; Amanda Brand; Janicke Visser
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.